This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Antibody Engineering & Therapeutics US
December 15 - 18, 2024
Marriott Marquis San DiegoLive In-Person Event: December 15 - 18, 2024

Yu Liang, PhD
Vice President, Research & Development at GenScript ProBio USA Inc.


Dr. Yu Liang has over 20 years of research experience spanning academia and industry. He currently serves as VP for R&D at GenScript ProBio. Previously, he was a PI at Novartis and WuXi Biologics. His broad expertise covers cellular/molecular biology, virology, immunology, and early drug discovery of antibody therapeutics. He received his PhD in Virology/Microbiology from the University of Chicago and completed his postdoctoral training at NIH.

Agenda Sessions

  • Accelerating Chimeric Antigen Receptor Discovery: From Targets to Leads with ProCAR™ Platform